financetom
Business
financetom
/
Business
/
Market Chatter: SEC Investigates Publicly Traded Tech Firms' Foreign Partners to Weed Out Corruption
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: SEC Investigates Publicly Traded Tech Firms' Foreign Partners to Weed Out Corruption
Apr 3, 2024 5:49 AM

08:27 AM EDT, 04/03/2024 (MT Newswires) -- The Securities and Exchange Commission is investigating publicly traded tech firms' relationships with distributors and other partners outside the US in a move to combat corruption, Bloomberg reported Wednesday, citing unnamed sources.

As part of its enforcement of the Foreign Corrupt Practices Act, the regulator has been contacting tech companies to find out if they have worked with a list of dozens of intermediaries, some of which have been implicated in other investigations, Bloomberg reported.

The Foreign Corrupt Practices Act prohibits bribing foreign officials, and requires publicly traded companies to maintain accurate books and records to provide assurances that deals are conducted and assets are accounted for in accordance with generally accepted accounting principles.

The FCPA, which can apply to prohibited conduct anywhere in the world, extends to publicly traded companies as well as their officers, directors, employees, agents, and stockholders.

Representatives from the SEC did not immediately respond to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zymeworks Receives FDA Clearance for Investigational New Drug Application for Cancer Therapy
Zymeworks Receives FDA Clearance for Investigational New Drug Application for Cancer Therapy
Jul 22, 2024
07:53 AM EDT, 07/22/2024 (MT Newswires) -- Zymeworks ( ZYME ) said on Monday that the Food and Drug Administration has cleared the investigational new drug application for its experimental cancer therapy, ZW191. The company said it plans to seek regulatory approval to start clinical trials for ZW191 in countries outside the US by H2 2024. ZW191 is the first...
Top Premarket Gainers
Top Premarket Gainers
Jul 22, 2024
07:56 AM EDT, 07/22/2024 (MT Newswires) -- Tellurian (TELL) shares surged 65% in recent Monday premarket activity, a day after saying it signed a definitive agreement with Woodside Energy Group ( WDS ) , under which the latter will acquire all the outstanding shares of Tellurian for $1 per share in an all-cash transaction of about $900 million. Castellum (CTM)...
Vista Outdoor Increases Sale Price for The Kinetic Group to $2.15 Billion; Reaffirms Fiscal 2025 Sales Guidance
Vista Outdoor Increases Sale Price for The Kinetic Group to $2.15 Billion; Reaffirms Fiscal 2025 Sales Guidance
Jul 22, 2024
07:59 AM EDT, 07/22/2024 (MT Newswires) -- Vista Outdoor ( VSTO ) said Monday it signed a deal to increase its selling price for The Kinetic Group business to Czechoslovak Group by $50 million. The purchase price was increased to $2.15 billion from the original price of $1.91 billion, Vista said, adding that about $125 million would be added as...
Ero Copper Signs Definitive Agreement to Acquire 60% of Furnas Project in Brazil
Ero Copper Signs Definitive Agreement to Acquire 60% of Furnas Project in Brazil
Jul 22, 2024
07:53 AM EDT, 07/22/2024 (MT Newswires) -- Ero Copper ( ERO ) said on Monday that it signed a definitive agreement with Salobo Metais, a subsidiary of Vale Base Metals, to buy a 60% interest in the Furnas copper project in Brazil. Under the terms of a binding term sheet announced in October 2023, Ero must complete three phases of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved